Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol in stable coronary artery disease
NCT02174939Phase 4Unknown
- Sponsor
- National Cheng Kung University Hospital
- Start
- Feb 2014
- Primary completion
- Oct 2017
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol in coronary artery disease (CAD), sponsored by National Cheng Kung University Hospital. Status: unknown.
02
Drugs
cilostazol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02174939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02174939.